Skip to main navigation Skip to search Skip to main content

Effect of Low-dose Intravitreal Bevacizumab and Ranibizumab on Regression and Late Reactivation in Retinopathy of Prematurity in the Treatment-Naïve Eyes

  • SUNY Buffalo
  • West Virginia University

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)328-330
Number of pages3
JournalOphthalmology Retina
Volume6
Issue number4
DOIs
StatePublished - Apr 2022

Keywords

  • bevacizumab
  • pediatrics
  • ranibizumab
  • retina
  • ROP

Fingerprint

Dive into the research topics of 'Effect of Low-dose Intravitreal Bevacizumab and Ranibizumab on Regression and Late Reactivation in Retinopathy of Prematurity in the Treatment-Naïve Eyes'. Together they form a unique fingerprint.

Cite this